Could a simple nutrient shake help preemies breathe easier?
NCT ID NCT07307612
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding DHA/ARA supplements to the milk of extremely premature babies (born at 28 weeks or earlier) during their first two weeks of life can reduce the severity of bronchopulmonary dysplasia, a chronic lung disease. About 150 babies will be randomly assigned to receive either standard fortified human milk or the same milk with extra DHA/ARA. Researchers will then measure breathing support needs at 36 weeks and lung function later on.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DHA/ARA supplement added to fortified human milk
What this could lead to
If it works, this could lead to a simple nutritional strategy that lowers the risk of chronic lung disease in extremely premature babies.
What could go wrong
This is an early-phase trial with only 150 babies, so results may not be conclusive. The supplement might not improve lung outcomes, and there could be digestive or other side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States